Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21546878 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)
Condition: Hypercholesteremia
Intervention: Drug: Rosuvastatin calcium

Indicates status has not been verified in more than two years